BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36941076)

  • 1. Trends in the age of hospitalized patients with urological cancers: A 17-year experience.
    Ishii N; Hatakeyama S; Miura H; Tanaka R; Oishi T; Horiguchi H; Hosogoe S; Fujita N; Iwamura H; Okamoto T; Yamamoto H; Yoneyama T; Hashimoto Y; Ohyama C
    Int J Urol; 2023 Jul; 30(7):572-578. PubMed ID: 36941076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes.
    Saito K; Kihara K
    Int J Urol; 2013 Feb; 20(2):161-71. PubMed ID: 22897628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers.
    Soma O; Hatakeyama S; Okamoto T; Fujita N; Hamano I; Tanaka T; Momota M; Yoneyama T; Yamamoto H; Imai A; Yoneyama T; Hashimoto Y; Yoshikawa K; Kawaguchi T; Saitoh H; Nakaji S; Suzuki T; Ohyama C
    Med Oncol; 2019 Sep; 36(10):88. PubMed ID: 31520152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary urological cancers in a context of limited resources: Epidemiology and treatment].
    Ouedraogo S; Traore MT; Kambire JL; Ouedraogo S; Bere B; Kabore AF
    Bull Cancer; 2019 Oct; 106(10):868-874. PubMed ID: 31350015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [De novo urologic tumors in kidney transplant patients].
    Rodríguez Faba O; Breda A; Gausa L; Palou J; Villavicencio H
    Actas Urol Esp; 2015 Mar; 39(2):122-7. PubMed ID: 24996779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [De novo urological neoplasms in kidney transplant patients: experience in 1,751 patients].
    di Capua Sacoto C; Luján Marco S; Bahilo Mateu P; Budía Alba A; Pontones Moreno JL; Jiménez Cruz JF
    Actas Urol Esp; 2010 Jan; 34(1):88-94. PubMed ID: 20223138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of incidence of urological cancer in South Korea: a 15-year summary.
    Cheon J; Kim CS; Lee ES; Hong SJ; Cho YH; Shin EC; Lee WC; Yoon MS
    Int J Urol; 2002 Aug; 9(8):445-54. PubMed ID: 12225342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does solitary- and organ-confined metastasectomy really improve survival in advanced urologic malignancies?
    Tonyali S; Yazici S
    Int Urol Nephrol; 2016 May; 48(5):671-80. PubMed ID: 26843415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent renal cell carcinoma and urothelial carcinoma: long-term follow-up study of 27 cases.
    Qi N; Chen Y; Gong K; Li H
    World J Surg Oncol; 2018 Jan; 16(1):16. PubMed ID: 29370814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern of urological malignancy in Zambia. A hospital-based histopathological study.
    Elem B; Patil PS
    Br J Urol; 1991 Jan; 67(1):37-9. PubMed ID: 1847087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gout patients have an increased risk of developing most cancers, especially urological cancers.
    Chen CJ; Yen JH; Chang SJ
    Scand J Rheumatol; 2014; 43(5):385-90. PubMed ID: 24825466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological characteristics and outcomes of synchronous renal cell carcinoma and urothelial carcinoma: A population-based analysis.
    Wu K; Liu X; Wang Y; Wang X; Li X
    Front Public Health; 2022; 10():994351. PubMed ID: 36388369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between cannabis use with urological cancers: A population-based cohort study and a mendelian randomization study in the UK biobank.
    Huang J; Huang D; Ruan X; Huang J; Xu D; Heavey S; Olivier J; Na R
    Cancer Med; 2023 Feb; 12(3):3468-3476. PubMed ID: 35975633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. History of urological malignancies before kidney transplantation, oncological outcome on the long term.
    Boissier R; Hidalgo R; Rodríguez Faba O; Territo A; Subiela JD; Huguet J; Sánchez-Puy A; Gallioli A; Vanacore D; Mercade A; Martinez C; Palou J; Guirado L; Breda A
    Actas Urol Esp (Engl Ed); 2021 Dec; 45(10):623-634. PubMed ID: 34764048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyruvate kinase type tumor M2 in urological malignancies.
    Hegele A; Varga Z; Kosche B; Stief T; Heidenreich A; Hofmann R
    Urol Int; 2003; 70(1):55-8. PubMed ID: 12566817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plastic exposure and urological malignancies - an emerging field.
    Patel SH; Metcalf M; Bivalacqua TJ; Kates M
    Nat Rev Urol; 2020 Dec; 17(12):653-654. PubMed ID: 33028980
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoimmune disease and subsequent urological cancer.
    Liu X; Ji J; Forsti A; Sundquist K; Sundquist J; Hemminki K
    J Urol; 2013 Jun; 189(6):2262-8. PubMed ID: 23228387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Features and Risk Factors of Skeletal-Related Events in Genitourinary Cancer Patients with Bone Metastasis: A Retrospective Analysis of Prostate Cancer, Renal Cell Carcinoma, and Urothelial Carcinoma.
    Owari T; Miyake M; Nakai Y; Morizawa Y; Itami Y; Hori S; Anai S; Tanaka N; Fujimoto K
    Oncology; 2018; 95(3):170-178. PubMed ID: 29874673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urologic cancer in China.
    Pang C; Guan Y; Li H; Chen W; Zhu G
    Jpn J Clin Oncol; 2016 Jun; 46(6):497-501. PubMed ID: 27049022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urologic tumors in the Federal Republic of Germany: data on 56,013 cases from hospital cancer registries.
    Fischer CG; Waechter W; Kraus S; Fuentecilla Perez E; Weidner W; Dudeck J
    Cancer; 1998 Feb; 82(4):775-83. PubMed ID: 9477112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.